HUMSCs Combined With Col I to Third-Degree Burn Wound

Recruiting now · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Burn Wounds, Third-Degree Burn Wounds

In brief

To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.

Key facts

Study ID

NCT07530003

Run by

The First Affiliated Hospital of Xinxiang Medical College

People needed

108

Starts

2026-04-06

Expected to finish

2028-12-31

Last updated by the study team

2026-05-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18-65 years, gender unrestricted
• Confirmed third-degree burns, wound area 1%-5% TBSA
• Admission within 72 hours after burn injury
• Voluntarily signed informed consent
• Able to cooperate and complete follow-up

You may not qualify if…

• Pregnant or lactating females
• Severe immunodeficiency or autoimmune disease
• History of malignant tumor, or coagulation dysfunction
• Severe cardiac, hepatic, or renal insufficiency
• Hypersensitivity to collagen or stem cell components
• Uncontrollable severe wound infection
• Participation in other clinical studies within the past 3 months
• Inability to comply with follow-up

Where it is running

• The First Affiliated Hospital of Xinxiang Medical College — Xinxiang, Henan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.